266 related articles for article (PubMed ID: 15656392)
1. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
[TBL] [Abstract][Full Text] [Related]
3. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
Fragasso G; Salerno A; Lattuada G; Cuko A; Calori G; Scollo A; Ragogna F; Arioli F; Bassanelli G; Spoladore R; Luzi L; Margonato A; Perseghin G
Heart; 2011 Sep; 97(18):1495-500. PubMed ID: 21700755
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
5. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine shortens QTc interval in patients with ischemic heart failure.
Zemljic G; Bunc M; Vrtovec B
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):31-6. PubMed ID: 19966175
[TBL] [Abstract][Full Text] [Related]
8. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
Ma QL; Xie Y; Zhang SD
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):527-9. PubMed ID: 12658930
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Kolomoets NM; Baksheev VI; Uvaĭsova KU
Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
[TBL] [Abstract][Full Text] [Related]
10. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
[TBL] [Abstract][Full Text] [Related]
11. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
Zhubrina ES; Ovchinnikov AG; Seredenina EM; Patrusheva IF; Blankova ZN; Kuz'mina AE; Kheĭmets GI; Ageev FT
Ter Arkh; 2009; 81(11):35-40. PubMed ID: 20141011
[TBL] [Abstract][Full Text] [Related]
12. [Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
Tepliakov AT; Sankevich qV; Stepacheva TA; Garganeeva AA; Filippov EA; Pushnikova EIu; Kaliuzhin VV; Efimova I; Zavadovskiĭ KV
Klin Med (Mosk); 2004; 82(5):57-62. PubMed ID: 15230045
[TBL] [Abstract][Full Text] [Related]
13. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
14. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
Klecha A; Kawecka-Jaszcz K; Bacior B; Kubinyi A; Pasowicz M; Klimeczek P; Banyś R
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):85-91. PubMed ID: 17301632
[TBL] [Abstract][Full Text] [Related]
15. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
Sisakian AS; Torgomian AL; Barkhudarian AL
Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276
[TBL] [Abstract][Full Text] [Related]
16. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
17. [Trimetazidine effects on postinfarction remodeling of the left ventricle].
Kokov AN; Tarasov II; Barbarash LS
Ter Arkh; 2005; 77(8):10-4. PubMed ID: 16206598
[TBL] [Abstract][Full Text] [Related]
18. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
[TBL] [Abstract][Full Text] [Related]
19. [Effect of combination therapy with preduktal and prestarium on the left ventricular function in the postinfarction period].
Dzhindzholiia NR; Megreladze II
Georgian Med News; 2008 Feb; (155):20-3. PubMed ID: 18401050
[TBL] [Abstract][Full Text] [Related]
20. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
Cera M; Salerno A; Fragasso G; Montanaro C; Gardini C; Marinosci G; Arioli F; Spoladore R; Facchini A; Godino C; Margonato A
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):24-30. PubMed ID: 20100903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
